If Liberal Leader Mark Carney thinks Danielle Smith is just going to go away he has got another thing coming. The smart money says this will shape up to be a battle Carney will not be able to ...

The results could be harmful to them in more ways than one. Despite this issue, Eli Lilly remains a top stock to buy. As everyone who follows equity markets knows, stocks are feeling the heat from ...

Climb Off the Trump Tightrope, Danielle Smith More Than 300,000 Alberta Workers Form a United Front Looking for Election Insights? Join ‘The Run’ Except, of course, for that time when ...

April 8 - Eli Lilly (NYSE:LLY) shares rose about 5% Tuesday morning after Goldman Sachs (NYSE:GS) upgraded the pharmaceutical giant to Buy from Neutral, citing confidence in its leadership in the ...

Danielle Smith isn’t taking any guff from Mark Carney, the Liberal Leader and prime minister, this day or any day. He was no doubt feeling cocky looking at the sweet poll numbers, so he decides ...

Alberta premier claims it will attract surgeons and save money – neither is likely to be true. Alberta Premier Danielle Smith at a press conference alongside Alberta Health Minister Adrianna LaGrange.

A new research note was upbeat about selected "semis" like Lam. Bank of America feels the company, plus a handful of others, is relatively well positioned to ride out the current storm over tariffs.

“Hi, sister.” That’s how Mark-Paul Gosselaar greeted Danielle Savre at her trailer on the set of Found. Savre joined the show for Season 2 as Heather, a lawyer who is Trent’s (Brett ...

Eli Lilly & Co.’s shares fell Monday morning after the Trump administration spiked a plan late last week to pay for obesity drugs for Medicare patients. The Centers for Medicare and Medicaid ...

Eli Lilly and Co. is suing an Indianapolis-based weight-loss clinic it says is improperly selling Lilly’s hugely popular diabetes and weight-loss drugs. In a lawsuit filed in a federal district ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds industry ...

Eli Lilly has recently announced several developments, including positive Phase 2 results for their siRNA therapy lepodisiran and the expansion of their digital healthcare platform, LillyDirect ...